Immunai

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Immunai's mission is to transform immunology by pioneering single-cell technologies coupled with the most cutting-edge AI methods. Immunai is a venture funded start-up headquartered in NYC.

Immunai's Scientific Advisory Board includes Dan Littman, Eran Segal, Regina Barzilai, Anshul Kundaje, and has strategic partnerships with some of the most prestigious oncology centers in the world.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
DeepImmune
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Sr. Data Scientist
Parker Institute for Cancer Immunotherapy